INmune Bio Inc

NASDAQ INMB

Data sourced from iex and EODHD
Download Data

INmune Bio Inc Income Statement 2016 - 2024

This table shows the Income Statement for INmune Bio Inc going from 2016 until 2024. The income statement, also known as the profit and loss statement, is a financial statement that provides a summary of a company's revenues, expenses, and net income over a specific period (such as a quarter or a year). It shows the company's ability to generate revenue, manage expenses, and ultimately determine its profitability.
Income Statement Trend Unit 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-12-31 2017-09-30 2016-12-31
Revenue
M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 78 0 0 0 0 0 0 0 0 - -
Cost of Revenue
M - - - - - - - - - - - - - - - - - - - - - 0 0 0 0 0 - -
Gross Profit
M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - - - 78 - - - 0 0 0 0 0 - -
Operating Expenses
M 11 8 9 6 6 6 8 6 7 9 9 7 5 3 - - - 80 - - - 2 2 6 3 0 - -
Selling, General, and Administrative Expenses (SG&A)
M 2 2 3 2 2 2 2 2 2 2 3 2 2 1 2 1 1 1 2 2 2 1 1 6 3 0 0 0
Research and Development (R&D) Expenses
M 9 6 6 4 4 3 5 4 4 7 7 4 2 2 2 1 1 1 1 0 0 1 0 0 0 0 0 0
Other Operating Expenses
M 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - - - 78 - - - 0 0 0 0 0 - -
Costs and Expenses
M - - - - - - - - - - - - - - - - - - - - - 2 2 6 3 0 - -
Operating Income
M -11 -8 -9 -6 -6 -6 -7 -6 -6 -9 -9 -7 -5 -3 -5 -2 -2 -2 -3 0 -2 -2 -2 -6 -3 0 0 -
Interest Expense
M - 0 - - 0 0 0 0 0 21 - - - - - - 0 - - - - - - - - - - -
Non-operating Income/Expense
M 0 0 0 0 0 0 0 0 0 -1 0 0 0 0 0 0 0 0 0 2 0 -12,440 0 0 0 0 - -
EBT
M -11 -8 -9 -7 -7 -6 -8 -7 -7 -10 -9 -7 -5 -3 -5 -2 -2 -2 -3 0 -2 -2 -2 -6 -3 0 0 -
Income Tax Provision
M -11 15 -9 -6 0 0 0 0 0 21 - - - - - - - - - 2 - 0 0 0 0 0 - -
Income after Tax
M 0 -23 0 0 -7 -6 -8 -7 -7 -31 - - - - - - - - - -2 - -2 -2 -6 -3 0 - -
Non-Controlling Interest
M - - - 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - -
Net Income
M - - - -7 -7 -6 -8 -7 -7 -10 -9 -7 -5 -3 -5 -2 -2 -2 -3 0 -2 -2 -2 -6 -3 0 - -
Shares (Basic, Weighted)
M - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Shares (Diluted, Weighted)
R 18,026,473.00 17,950,776.00 18,008,295.00 17,945,995.00 17,945,995.00 17,329,379.00 17,945,995.00 17,945,995.00 17,870,285.00 17,329,379.00 17,329,379.00 14,974,953.00 14,322,659.00 12,926,539.00 12,926,539.00 10,800,708.00 10,747,300.00 10,747,300.00 10,762,473.00 10,150,810.00 9,388,645.00 11,219,441.00 11,219,441.00 11,219,441.00 11,219,441.00 11,219,441.00 11,219,441.00 -
EBITDA
M -11 -8 -9 -6 -6 -6 -7 -6 -6 -9 -9 -7 -5 -3 -5 -2 -2 -2 -3 -4 -2 -2 -2 -6 -3 0 0 -
Depreciation and Amortization
M 11 -21 9 6 6 1 0 0 0 -21 - - - - - - - - - -3 - - - - - - - -
EBIT
M -22 13 -17 -13 -13 -7 -7 -6 -6 12 -9 -7 -5 -3 -5 -2 -2 -2 -3 0 -2 -2 -2 -6 -3 0 - -
Income from Discontinued Operations
M - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Tax Rate (Effective)
% 99.93 -176.33 99.59 98.62 -1.73 -3.27 -3.65 -6.58 -6.16 -220.35 - - - - - - - - - -384.02 - 0.00 0.00 0.00 0.00 0.00 - -
Earnings Per Share (EPS), Basic
M - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Earnings Per Share (EPS), Diluted
M - - - 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 - -
Gross Profit Margin
% 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 - - - 100.00 - - - - - - - - - -
Operating Income Margin
% -78,692.86 -29,925.00 -19,832.56 -13,936.96 -16,902.63 -5,816.49 -7,594.90 -39,925.00 -3,974.23 -5,539.88 -64,435.71 -163,850,000.00 -113,700.00 -29,395.93 - - - -3.00 - - - - - - - - - -
Net Income Margin
% - - - -14,132.61 -17,200.00 -6,013.40 -7,882.65 -42,737.50 -4,234.97 -5,933.13 -67,557.14 -166,375,000.00 -113,900.00 -29,354.03 - - - -2.98 - - - - - - - - - -
EBITDA Ratio
% -78,692.86 -29,925.00 -19,832.56 -13,936.96 -16,902.63 -5,816.49 -7,594.90 -39,925.00 -3,974.23 -5,539.88 -64,435.71 -163,850,000.00 -113,700.00 -29,395.93 - - - -3.00 - - - - - - - - - -
EBIT Ratio
% -157,385.71 46,367.86 -39,665.12 -27,873.91 -33,805.26 -7,009.28 -7,594.90 -39,925.00 -3,974.23 7,533.74 -67,557.14 -163,850,000.00 -113,900.00 -29,354.03 - - - -2.98 - - - - - - - - - -
EBT Ratio
% -78,750.00 -30,028.57 -19,913.95 -14,132.61 -17,200.00 -6,013.40 -7,882.65 -42,737.50 -4,234.97 -5,933.13 -67,557.14 -166,375,000.00 -113,900.00 -29,354.03 - - - -2.98 - - - - - - - - - -

StockViz Staff

September 19, 2024

Any question? Send us an email